Phibro Animal Health Corporation (PAHC) Given “Buy” Rating at Piper Jaffray Companies

Piper Jaffray Companies restated their buy rating on shares of Phibro Animal Health Corporation (NASDAQ:PAHC) in a research report released on Friday. Piper Jaffray Companies currently has a $42.00 price target on the stock.

A number of other analysts have also recently weighed in on the stock. Credit Suisse Group raised their price objective on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an outperform rating in a report on Thursday, August 31st. BidaskClub cut shares of Phibro Animal Health Corporation from a strong-buy rating to a buy rating in a report on Wednesday, August 23rd. Bank of America Corporation reissued an underperform rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a hold rating to a buy rating and set a $41.00 price objective on the stock in a report on Tuesday, October 31st. Finally, ValuEngine cut shares of Phibro Animal Health Corporation from a buy rating to a hold rating in a report on Thursday. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of $38.25.

Phibro Animal Health Corporation (NASDAQ PAHC) traded up $0.45 during mid-day trading on Friday, reaching $34.60. 74,500 shares of the company’s stock were exchanged, compared to its average volume of 78,865. The company has a current ratio of 3.26, a quick ratio of 1.75 and a debt-to-equity ratio of 1.91. Phibro Animal Health Corporation has a 12 month low of $26.10 and a 12 month high of $40.25. The firm has a market capitalization of $1,380.09, a PE ratio of 22.61, a P/E/G ratio of 4.06 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Phibro Animal Health Corporation had a net margin of 8.87% and a return on equity of 42.75%. The company had revenue of $193.40 million for the quarter, compared to analysts’ expectations of $189.89 million. During the same quarter last year, the company earned $0.36 earnings per share. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. equities analysts predict that Phibro Animal Health Corporation will post 1.57 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) Given “Buy” Rating at Piper Jaffray Companies” was first posted by Markets Daily and is the property of of Markets Daily. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.themarketsdaily.com/2017/11/12/phibro-animal-health-corporation-pahc-given-buy-rating-at-piper-jaffray-companies.html.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be issued a $0.10 dividend. The ex-dividend date is Tuesday, December 5th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.16%. Phibro Animal Health Corporation’s payout ratio is 23.53%.

In other news, COO Larry Lee Miller sold 32,459 shares of Phibro Animal Health Corporation stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $35.59, for a total value of $1,155,215.81. Following the transaction, the chief operating officer now directly owns 4,237 shares of the company’s stock, valued at approximately $150,794.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction on Friday, September 15th. The shares were sold at an average price of $35.70, for a total transaction of $357,000.00. Following the completion of the transaction, the insider now directly owns 10,000 shares in the company, valued at $357,000. The disclosure for this sale can be found here. Insiders sold a total of 292,448 shares of company stock worth $10,624,994 over the last ninety days. Corporate insiders own 51.88% of the company’s stock.

Large investors have recently bought and sold shares of the stock. State of Alaska Department of Revenue grew its position in Phibro Animal Health Corporation by 80.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan grew its position in Phibro Animal Health Corporation by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. KBC Group NV purchased a new position in Phibro Animal Health Corporation in the 2nd quarter valued at $166,000. Victory Capital Management Inc. grew its position in Phibro Animal Health Corporation by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock valued at $199,000 after buying an additional 807 shares during the last quarter. Finally, Capital Fund Management S.A. purchased a new position in Phibro Animal Health Corporation in the 2nd quarter valued at $210,000. Hedge funds and other institutional investors own 49.87% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply